In the last hour, Binance experienced a net outflow of 37.3491 million Tether (USDT), equivalent to 3,734.91 wan USDT. This indicates a short-term transfer of funds away from the exchange. Such movements can reflect traders' shifting strategies or reactions to market conditions, potentially impacting liquidity and price stability on Binance. Monitoring these flows helps investors gauge market sentiment and anticipate volatility.
Binance's recent net outflow of 37.3491 million Tether (USDT) provides context for digital asset movements. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Sep 25, 2026 19:31 WIB: out of 50 major cryptocurrencies priced on Pluang, 44 rose and 5 fell today. Notable movers include ADA at Rp4.595 with a 1-day change of +8.58%, KSM at Rp84.762 with +8.57%, and SNX at Rp4.613 with +8.18%.
Assured Guaranty Ltd. (NYSE: AGO) saw its stock price pressured to a new 52-week low of $68.04 despite a recent upgrade to "Buy" by Roth Capital. The company is involved in the financial restructuring of Brightline Florida, where a subsidiary insured...
Legacy Education Inc. reported Q4 2026 earnings with an EPS of $0.13, missing analyst estimates of $0.15, and revenue of $20.1 million, slightly below expectations. Despite this, the company achieved a 12% year-over-year revenue increase in Q4 and a ...
Carnival Corporation & plc is set to report Q3 earnings with analysts forecasting $8.39 billion in revenue and $1.36 EPS, reflecting a 4.9% decline from last year. The company's stock has dropped 27% recently due to a 30% surge in Brent oil prices, w...
Oklo, a pre-revenue nuclear tech company, is developing advanced small modular reactors (SMRs) called Aurora Powerhouses aimed at clean energy for data centers. UBS set a price target of $41, indicating a 7.08% upside from the current $38.29 stock pr...
Barclays initiated coverage on Ligand Pharmaceuticals with an 'Overweight' rating and set a price target of $345, implying a 15.37% upside from its current price. The biopharma company is expanding its royalty portfolio through investments in cancer ...
